Measuring high-sensitivity cardiac troponin T blood concentration in population surveys

Antonio Ivan Lazzarino1,2, Jennifer S Mindell2

  • 1London School of Hygiene & Tropical Medicine, London, United Kingdom.

Plos One
|February 1, 2017
PubMed

Insights

High-sensitivity cardiac troponin T (HS-CTnT) blood tests are feasible for large population surveys. Stored samples showed reliable cardiovascular risk marker results, supporting their use in national health assessments.

Area of Science:

  • Cardiovascular Disease Biomarkers
  • Population Health Surveys
  • Clinical Chemistry

Background:

  • High-sensitivity cardiac troponin T (HS-CTnT) is a proposed cardiovascular risk marker in the general population.
  • HS-CTnT levels correlate with future cardiovascular events and mortality.
  • Feasibility of HS-CTnT testing in large, nationally-representative surveys needs evaluation.

Purpose of the Study:

  • To assess the feasibility of measuring HS-CTnT in samples collected during household visits.
  • To determine if standard postal shipping and freezing affect HS-CTnT test results.
  • To evaluate the test-retest reliability of HS-CTnT measurements after storage.

Main Methods:

  • Utilized blood samples from 200 participants in the Health Survey for England (HSE) 2016.
  • Stored samples at -40°C for 5-10 weeks before retesting.
  • Analyzed within-person agreement using Cronbach's Alpha and Interclass Correlation Coefficient.

Main Results:

  • High reliability was observed, with Cronbach's Alpha at 0.97 and ICC at 0.95.
  • No significant impact on results was found from the delay (1-4 days) between blood withdrawal and storage.
  • Freezing time (5-10 weeks) did not affect the accuracy of HS-CTnT measurements.

Conclusions:

  • Measuring HS-CTnT plasma concentration is feasible within large, nationally-representative surveys like the HSE.
  • Standard sample handling, shipping, and storage protocols are compatible with reliable HS-CTnT testing.
  • This supports the integration of HS-CTnT testing into routine population health surveillance for cardiovascular risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
670
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.3K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
258